Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
详细信息 查看全文
- 作者：Kohei Shitara ; Keisho Chin ; Takaki Yoshikawa ; Hitoshi Katai…
- 关键词：Stage III gastric cancer ; Adjuvant chemotherapy ; Oxaliplatin ; S ; 1 ; S ; 1 and oxaliplatin
- 刊名：Gastric Cancer
- 出版年：2017
- 出版时间：January 2017
- 年：2017
- 卷：20
- 期：1
- 页码：175-181
- 全文大小：352KB
- 刊物类别：Medicine
- 刊物主题：Surgical Oncology; Oncology; Abdominal Surgery; Gastroenterology; Cancer Research;
- 出版者：Springer Japan
- ISSN：1436-3305
- 卷排序：20
文摘
BackgroundThe Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer (ACTS-GC) demonstrated a survival benefit by adjuvant S-1 monotherapy in patients who had undergone curative resection of stage II/III gastric cancer, but there is still a need to improve the efficacy of treatment of stage III disease. We investigated the tolerability and safety of S-1 and oxaliplatin as adjuvant chemotherapy for stage III gastric cancer.